Stock report · Delisted · Nasdaq
Opthea Limited (OPTEY)
0.03USD Delisted Final close · Jul 22, 2026
OPTEY no longer trades. Opthea was delisted from the Nasdaq in July 2026.
All prices on this page are historical. The last trade was on July 22, 2026, at $0.03.
OPTEY stock price history
Final trading statistics
- Final close
- $0.03
- Final trading day
- Jul 22, 2026
- Market cap at delisting
- $5.81M
- Shares outstanding
- 171.00M
- Final 52-week range
- $0.00 – $3.41
- Avg. volume (final 3 mo.)
- 26,068
- All-time high
- $21.36 · Jan 2020
- All-time low
- $0.01 · Jan 2026
- Return since IPO
- -99.1%
- Beta
- 1.53
- Book value / share
- $0.14
- Price / book
- 0.25
About Opthea Limited
Opthea Limited, renamed Ceryvyn Therapeutics Limited in July 2026, was a clinical-stage biopharmaceutical company in Australia and the U.S. Its research targeted vascular endothelial growth factors (VEGF) C, D and R3.
Its main candidate, Sozinibercept, was in phase 3 for wet age-related macular degeneration (Wet AMD) and in phase 2 for diabetic macular edema (DME). The company served the biotech and healthcare sectors. Incorporated in 1984, it was based in Melbourne, Australia.
It was delisted from the Nasdaq in July 2026, with a last trade on July 22, 2026 at $0.03.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Melbourne, VIC
- Employees
- —
- IPO date
- April 12, 2012
- Delisted
- July 22, 2026
Opthea financials before the delisting
The last 4 fiscal years Opthea reported as a public company, fiscal year ending June.
OPTEY revenue and net income
OPTEY earnings per share
OPTEY annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $25.0K | −$162.8M | −$0.14 |
| FY2024 | $125.0K | −$220.2M | −$2.80 |
| FY2023 | $108.0K | −$142.5M | −$2.10 |
| FY2022 | $90.7K | −$92.8M | −$0.37 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Opthea stock FAQ
What happened to Opthea stock?
Opthea was delisted from the Nasdaq in July 2026. The final close was $0.03 on July 22, 2026.
Can I still buy OPTEY stock?
No. OPTEY is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on July 22, 2026.
What was the last price of OPTEY?
OPTEY last closed at $0.03 on July 22, 2026, which valued the company at about $5.81M.
How did Opthea do in its last full fiscal year?
In fiscal 2025, its last full year as a public company, Opthea reported revenue of $25.0K and net income of −$162.8M.
When did Opthea go public?
Opthea shares started trading on April 12, 2012.
OPTEY no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.